Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy

Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy

June 16, 2025

Jared Holz, Mizuho, joins ‘Fast Money’ to talk the fallout for Sarepta after another death related to its muscular dystrophy gene therapy.

Share This

Latest Mizuho News

Payment stocks down due policy uncertainty, says Mizuho’s Dan Dolev

Payment stocks down due policy uncertainty, says Mizuho’s Dan Dolev

January 13, 2026

Why Dutch Bros is a top stock pick for 2026, while Starbucks lags

Why Dutch Bros is a top stock pick for 2026, while Starbucks lags

December 23, 2025

Keeping current furniture tariff rates benefits home furnishings sector: Mizuho’s Bellinger

Keeping current furniture tariff rates benefits home furnishings sector: Mizuho’s Bellinger

January 2, 2026

Mizuho news from around the globe

Mizuho Global News